SalaryGuide
AboutPricingBlogFor Employers

Marketing jobs

6 marketing jobs

Insulet Corporation logo
10 days ago

Senior Manager, US Field Marketing Tools - Acton, MA/San Diego, CA (Hybrid)

Insulet Corporation

San Diego, CA (Hybrid)Full time$136K/yr – $205K/yr
Insulet Corporation logo
7 weeks ago

Director of Customer Long-term Success and Loyalty - Acton, MA / San Diego, CA (Hybrid)

Insulet Corporation

San Diego, CA (Hybrid)Full time$187K/yr – $281K/yr
Insulet Corporation logo
1 month ago

Director, Product Marketing

Insulet Corporation

Acton, MA (Hybrid)Full time$187K/yr – $281K/yr
Insulet Corporation logo
2 months ago

Marketing Specialist (HYBRID - Acton, MA or San Diego, CA)

Insulet Corporation

San Diego, CA (Hybrid)Full time$64K/yr – $96K/yr
Insulet Corporation logo
4 months ago

Senior Director, Global Performance Marketing Accelerator (Hybrid-Acton, MA or San Diego, CA)

Insulet Corporation

Acton, MA (Hybrid)Full time$202K/yr – $303K/yr
Insulet Corporation logo
4 months ago

Senior Director, Global Performance Marketing Accelerator

Insulet Corporation

Acton, MA (Hybrid)Full time$202K/yr – $303K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

6 jobs
Insulet Corporation logo

Senior Manager, US Field Marketing Tools - Acton, MA/San Diego, CA (Hybrid)

Insulet Corporation

San Diego, CA (Hybrid)

$136K/yr - $205K/yrIn-houseFull-timeSenior level10+ years exp.
10 days ago
Insulet Corporation logo

Director of Customer Long-term Success and Loyalty - Acton, MA / San Diego, CA (Hybrid)

Insulet Corporation

San Diego, CA (Hybrid)

$187K/yr - $281K/yrIn-houseFull-timeDirector/executive15+ years exp.
7 weeks ago
Insulet Corporation logo

Director, Product Marketing

Insulet Corporation

Acton, MA (Hybrid)

$187K/yr - $281K/yrIn-houseFull-timeDirector/executive8+ years exp.
1 month ago
Insulet Corporation logo

Marketing Specialist (HYBRID - Acton, MA or San Diego, CA)

Insulet Corporation

San Diego, CA (Hybrid)

$64K/yr - $96K/yrIn-houseFull-timeMid level1+ years exp.
2 months ago
Insulet Corporation logo

Senior Director, Global Performance Marketing Accelerator (Hybrid-Acton, MA or San Diego, CA)

Insulet Corporation

Acton, MA (Hybrid)

$202K/yr - $303K/yrIn-houseFull-timeSenior level15+ years exp.
4 months ago
Insulet Corporation logo

Senior Director, Global Performance Marketing Accelerator

Insulet Corporation

Acton, MA (Hybrid)

$202K/yr - $303K/yrIn-houseFull-timeSenior level15+ years exp.
4 months ago
Insulet Corporation logo
Insulet Corporation

Senior Manager, US Field Marketing Tools - Acton, MA/San Diego, CA (Hybrid)

San Diego, CA (Hybrid)

$136K/yr – $205K/yrSenior Level10+ years expFull time

Posted 10 days ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Own and drive the strategy, planning, and rollout of field marketing tools and capabilities for diabetes segments, while coordinating with CRM, Marketing, Medical, and Agency partners to ensure compliant, integrated messaging and training.

  • Lead MLR/Veeva and approvals
  • Define KPIs and measure adoption
  • Build training and launch plans with cross-functional teams

Job Description

Responsibilities

  • Sales Marketing Tool Strategy & Execution: Lead strategy, planning, and execution of new field marketing tools and capabilities, including digital sales aids.
  • Collaborate with CRM, Sales Enablement, and Training teams to ensure platform integration.
  • Align with US HCP Marketing and Global Product Marketing to ensure consistent messaging and HCP marketing strategy execution across both Type 1 and Type 2 diabetes segments.
  • Manage the compliance & Cross-Functional Development
  • Own MLR/Veeva submission and approval processes.
  • Partner with HCP Marketing, Product Marketing, Medical, and Agency teams to ensure HCP strategy, compliance, and effective tool development.
  • Own launch plans for new field marketing tools and integrate into new hire and ongoing training programs.
  • Collaborate with GSCT and US Sales Training to build and hand off training content.
  • Manage ordering platform, including budgeting, inventory control, and quarterly audits.
  • Partner with US Marketing Events team to develop sales tool strategies for national and local events (e.g., ADA, Breakthrough Type 1, medical conferences, camps).

Requirements

  • Bachelor’s degree required, preferably in Business or Marketing (MBA or advanced degree preferred)
  • 10+ years of work experience.
  • 2+ years of medical device or pharmaceutical industry marketing experience preferred
  • Experience developing and commercializing field marketing tools and capabilities and new products/line extensions.
  • Diabetes experience or knowledge
  • Experience leading, motivating and managing a team
  • Proven ability to build cross-functional relationships and influence decision-makers.
  • Highly skilled in presenting strategies and tactics to senior-level audiences.
  • Deep experience using VEEVA and working within medical, legal, and regulatory functions

Preferred

  • MBA or advanced degree preferred
  • Diabetes experience or knowledge (Type 1 and/or Type 2) strongly preferred.

Benefits

  • Medical, dental, and vision insurance
  • 401(k) with company match
  • Paid time off (PTO)
  • And additional employee wellness programs
Insulet Corporation logo

Insulet Corporation

4.1 Glassdoor

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Omnipod products are offered in 25 countries around the globe.HIRING SCAM ALERT Recently, individuals impersonating Insulet Human Resources members have offered fraudulent interviews and job offers to unsuspecting candidates. To help protect you from these scam artists, please be aware that:•Insulet will never interview a candidate over RingCentral, similar messaging apps or social media (i.e. Google Hangouts, WhatsApp, Facebook Messenger, etc.), or via text message.•Insulet will never send a company check or ask an applicant to pay a fee or purchase at home work/training materials in connection with an application for employment.•Insulet will never provide excess money to an applicant and ask the applicant to write a check for repayment.If you have any doubt about a job offer or any other communication purporting to come from Insulet, please reach out to us directly at 978-600-7000.If you receive any type of communication on behalf of Insulet that seems inappropriate or suspicious, please report this activity to: www.iC3.gov or www.stopfraud.gov.

Founded in 2000
Acton, Massachusetts, USA
4.6K employees (227 in marketing)
www.insulet.com
80% recommend to a friend
85% CEO approval

Salaries

Posted range

$136K/yr – $205K/yr

Taken straight from the job posting.

See all Insulet Corporation salaries

Marketing Team

Marketing Team Size
167 (4% of company)
Median Career Experience
13.5 years
Median Tenure
4.6 years
Marketing Roles Posted (Last 30 Days)
1

People

Marketing Leadership

Linley Grandison
Linley Grandison
Vice President of Global Marketing Excellence
At the company for 2 years 7 months
Lindsay Philbrick
Lindsay Philbrick
Vice President Marketing
At the company for 11 years 7 months
Lucas Escobar
Lucas Escobar
Director, Head of US Consumer Marketing
At the company for 6 years 4 months
Matthew Vogel
Matthew Vogel
Sr. Director of Product Marketing
At the company for 11 months

Funding

Total Funding
$629.5M
Last Raise
$450M
Post IPO Debt, 12 months ago

Funding History

  • Mar 2025
    Post IPO Debt • $450M
  • Mar 2009
    Post IPO Debt • $60M
  • Feb 2006
    Series E • $50M

Traffic Signals

Monthly Visitors
167K
Traffic Source Mix
Search
40.3%
Direct
48.9%
Referral
8.7%
Social
0.8%
Paid
1.3%

Headcount Trend

Current headcount: ~4.6K

Recent News

Insulet wins FDA clearance for Omnipod 5 algorithm enhancements
Dec 4, 2025 • MassDevice
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
Dec 4, 2025 • Business Wire
Insulet Announces Next-Gen Omnipod 6 Coming in 2027
Dec 3, 2025 • HCPLive
Insulet: Excellent Business, Valuation Hurdle Remains
Dec 2, 2025 • Seeking Alpha
Diabetes Dialogue: Upcoming Upgrades for Omnipod Technology
Nov 26, 2025 • HCPLive
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
Nov 20, 2025 • Business Wire
Insulet to launch next-gen Omnipod 6 in 2027, outlines plans for fully closed loop pump for type 2
Nov 20, 2025 • MassDevice
Why Insulet (PODD) Might be Well Poised for a Surge
Nov 13, 2025 • Yahoo Finance
Insulet Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 9, 2025 • simplywall.st
Did Insulet's (PODD) Upbeat Quarter and Raised Outlook Just Shift Its Investment Narrative?
Nov 7, 2025 • Yahoo Finance
Insulet Corporation Reports Strong Q3 2025 Results
Nov 7, 2025 • The Globe and Mail
Insulet Corporation Reports Strong Q3 2025 Results
Nov 7, 2025 • TipRanks
Insulet Corp. Reveals Advance In Q3 Income
Nov 7, 2025 • Nasdaq
Insulet Corporation Reports Third Quarter 2025 Results
Nov 6, 2025 • TradingView
Insulet leadership talks patch pump competition, expanding type 2 diabetes market
Nov 6, 2025 • MassDevice
Jefferies raises Insulet stock price target to $400 on strong sales growth
Nov 6, 2025 • Investing.com
Insulet’s (NASDAQ:PODD) Q3: Strong Sales
Nov 6, 2025 • Yahoo Finance
Insulet Reports Third Quarter 2025 Results
Nov 6, 2025 • Business Wire
Ahead of Insulet (PODD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Nov 4, 2025 • Yahoo Finance
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
Oct 30, 2025 • Business Wire
RBC Capital Lifts Insulet (PODD) PT to $365 on Strong Momentum, Q3 Guidance Optimism
Oct 30, 2025 • Yahoo Finance
What to Expect From Insulet's Next Quarterly Earnings Report
Oct 24, 2025 • Yahoo Finance
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
Oct 23, 2025 • Yahoo Finance
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
Oct 23, 2025 • Business Wire
Insulet Corporation (PODD) Sees Higher 2025–2026 Revenue and Operating Margins, Says Canaccord
Oct 20, 2025 • Insider Monkey
Insulet Corporation $PODD Shares Sold by Aberdeen Group plc
Oct 13, 2025 • MarketBeat
Insulet to Host Investor Day on November 20, 2025
Oct 10, 2025 • Business Wire
Truist Securities Reiterates Buy Rating on Insulet (PODD) Stock
Oct 7, 2025 • Yahoo Finance
Insulet Corporation $PODD Shares Acquired by ASR Vermogensbeheer N.V.
Oct 5, 2025 • MarketBeat
Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance
Oct 1, 2025 • Yahoo Finance
Chicago Capital LLC Has $55.92 Million Stock Holdings in Insulet Corporation $PODD
Sep 30, 2025 • MarketBeat
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Sep 29, 2025 • Yahoo Finance
Patton Fund Management Inc. Makes New Investment in Insulet Corporation $PODD
Sep 28, 2025 • MarketBeat
Insulet Corporation $PODD Shares Acquired by Congress Asset Management Co.
Sep 27, 2025 • MarketBeat
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally?
Sep 26, 2025 • Zacks Investment Research
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally?
Sep 26, 2025 • Yahoo Finance
Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A.
Sep 23, 2025 • MarketBeat
3,137 Shares in Insulet Corporation $PODD Bought by Marshall Financial Group LLC
Sep 22, 2025 • MarketBeat
Swedbank AB Cuts Stock Position in Insulet Corporation $PODD
Sep 19, 2025 • MarketBeat
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
Sep 18, 2025 • Business Wire
Insulet Corporation (PODD) Benefited from Omnipod Sales
Sep 18, 2025 • Insider Monkey
Insulet Corporation (PODD) Benefited from Omnipod Sales
Sep 18, 2025 • Yahoo Finance
Insulet Hires Flavia Pease as Finance Chief
Sep 18, 2025 • Medical Product Outsourcing
Insulet stock price target maintained at $365 by Truist on strong growth
Sep 17, 2025 • Investing.com
Why Insulet (PODD) Shares Are Falling Today
Sep 17, 2025 • Yahoo Finance
Sheets Smith Investment Management Boosts Holdings in Insulet Corporation $PODD
Sep 17, 2025 • MarketBeat
Dexcom CEO goes on leave while Insulet taps new CFO
Sep 17, 2025 • FierceBiotech
Medical device maker Insulet taps industry veteran Flavia Pease as CFO
Sep 16, 2025 • Reuters
Insulet names new CFO; Dexcom CEO on leave
Sep 16, 2025 • MedTech Dive
Insulet makes CFO change, appoints longtime J&J leader
Sep 16, 2025 • MassDevice
Insulet Announces CFO Transition
Sep 16, 2025 • Business Wire
Insulet Announces CFO Transition
Sep 16, 2025 • BioSpace
Insulet Appoints Flavia Pease Finance Chief
Sep 16, 2025 • MarketScreener
Insulet Appoints Flavia Pease as CFO
Sep 16, 2025 • citybiz
Medical device maker Insulet names industry veteran Flavia Pease as CFO
Sep 16, 2025 • MarketScreener
Insulet expects to exceed Q3 revenue view of up 22%-25%
Sep 16, 2025 • thefly.com
Medical device maker Insulet taps industry veteran Flavia Pease as CFO
Sep 16, 2025 • MarketScreener
Insulet CFO Ana Maria Chadwick to leave role, Flavia Pease to succeed
Sep 16, 2025 • thefly.com
Charles River Labs CFO takes job at local medical device giant
Sep 16, 2025 • Seattle TechFlash
Here's Why Insulet (PODD) is a Strong Momentum Stock
Sep 15, 2025 • Yahoo Finance
Insulet stock hits all-time high at 350.92 USD
Sep 9, 2025 • Investing.com
Insulet Insider Sold Shares Worth $278,002, According to a Recent SEC Filing
Sep 9, 2025 • MarketScreener
Oppenheimer initiates coverage on Insulet stock with Outperform rating
Sep 8, 2025 • Investing.com
Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues Pushing Shares 26% Higher
Sep 6, 2025 • simplywall.st
Insulet at Wells Fargo Conference: Strategic Growth and Innovation
Sep 4, 2025 • Investing.com
Insulet promotes from within to fill CTO role
Sep 3, 2025 • Drug Delivery Business
Insulet’s SWOT analysis: patch pump pioneer’s stock faces growth hurdles
Sep 1, 2025 • Investing.com
Here's Why Insulet (PODD) is a Strong Growth Stock
Aug 27, 2025 • Yahoo Finance
Insulet Corporation stock hits 52-week high at 334.69 USD
Aug 27, 2025 • Investing.com
Insulet Stock: Analyst Estimates & Ratings
Aug 26, 2025 • Yahoo Finance
Insulet promotes Eric Benjamin to chief operating officer
Aug 26, 2025 • MedTech Dive
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
Aug 25, 2025 • Yahoo Finance
Insulet Elevates Eric Benjamin to Chief Operating Officer
Aug 25, 2025 • Business Wire
Insulet Gains 77.2% in a Year: What's Driving the Rally?
Aug 22, 2025 • Yahoo Finance
Insulet stock hits 52-week high at $329.55
Aug 20, 2025 • Investing.com
Insulet to Participate in Upcoming Investor Conferences
Aug 19, 2025 • Yahoo Finance
Insulet to Participate in Upcoming Investor Conferences
Aug 19, 2025 • Business Wire
Insulet's (NASDAQ:PODD) Conservative Accounting Might Explain Soft Earnings
Aug 14, 2025 • Yahoo Finance
There May Be Reason For Hope In Insulet's (NASDAQ:PODD) Disappointing Earnings
Aug 14, 2025 • simplywall.st
Insulet’s Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold (PODD)
Aug 13, 2025 • Seeking Alpha
Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise
Aug 12, 2025 • Yahoo Finance
Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise
Aug 12, 2025 • Nasdaq
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Aug 11, 2025 • Yahoo Finance
Insulet Insider Sold Shares Worth $429,760, According to a Recent SEC Filing
Aug 8, 2025 • MarketScreener
Insulet Corporation Q2 2025 Financial Results
Aug 7, 2025 • TradingView
Insulet (NASDAQ:PODD) Beats Expectations in Strong Q2, Stock Soars
Aug 7, 2025 • Yahoo Finance
Earnings call transcript: Insulet beats Q2 2025 forecasts, stock surges
Aug 7, 2025 • Investing.com
Insulet Corporation Reports Strong Q2 2025 Growth
Aug 7, 2025 • TipRanks
Insulet Corp. Q2 Profit Decreases, But Beats Estimates
Aug 7, 2025 • Nasdaq
Insulet up 13% at $313.45 after Q2 earnings beat and guidance raise
Aug 7, 2025 • thefly.com
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday
Aug 7, 2025 • Benzinga.com
Insulet sees Q3 revenue up 22%-25%
Aug 7, 2025 • thefly.com
Insulet reports Q2 adjusted EPS $1.17, consensus 92c
Aug 7, 2025 • thefly.com
Insulet beats second-quarter profit estimates on strong demand for insulin pumps
Aug 7, 2025 • Reuters
Transcript : Insulet Corporation, Q2 2025 Earnings Call, Aug 07, 2025
Aug 7, 2025 • MarketScreener
Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)
Aug 7, 2025 • Business Wire
Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5
Aug 7, 2025 • Benzinga.com
Insulet raises FY25 revenue view to up 24%-27% from 19%-22%
Aug 7, 2025 • thefly.com
Insulet Corporation Stock (PODD) Opinions on Analyst 'Moderate Buy' Rating
Aug 1, 2025 • Quiver Quantitative
Insulin Pumps Market Focused Insights Report 2025 | Global Insulin Pump Market to Hit USD 7.27 Billion by 2030 with a CAGR of 9.10% - ResearchAndMarkets.com
Jul 31, 2025 • Business Wire

Links

www.insulet.comLinkedInX (Twitter)Crunchbase